SARS-CoV-2 Omicron:病毒进化,免疫逃避和替代的持久治疗策略
Hailong Guo1, Sha Ha1, Jason W Botten2,3
1IGM Biosciences, Mountain View, CA 94043, USA.
Viruses
|May 25, 2024
概括
奥米克朗亚变种的进化驱动免疫逃生,使目前的治疗方法无效. 基于ACE2的疗法提供了针对正在演变的SARS冠状病毒的持久解决方案,包括Omicron.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 药物发现 药物发现 药物发现
背景情况:
- SARS-CoV-2 Omicron 变种的快速演变和突变导致了免疫逃脱,降低了现有的免疫治疗药物的疗效,并需要频繁更新疫苗.
- 了解Omicron的进化模式和免疫逃避机制对于重新评估流行病干预策略和开发新型治疗解决方案至关重要.
研究的目的:
- 审查Omicron病毒演化的重大事件,重点关注负责针对单克隆抗体和疫苗的免疫逃避的尖端突变.
- 提出替代的,持久的治疗选择,特别是基于ACE2的疗法,作为对抗Omicron演变的单克隆抗体的优越替代品.
主要方法:
- 关于SARS-CoV-2 Omicron进化,尖端蛋白突变和免疫逃避机制的科学文献的审查.
- 对目前针对Omicron亚型的免疫疗法和疫苗的疗效分析.
- 评估基于ACE2的实验性疗法作为潜在的广泛抗病毒药物.
主要成果:
- 奥米克朗的尖峰突变显著导致免疫逃避,危及单克隆抗体治疗和疫苗的有效性.
- 基于ACE2的实验性疗法在解决Omicron病毒演变方面显示出对单克隆抗体的潜在优势.
- 基于ACE2的病毒捕获分子在对抗一系列动物性SARS冠状病毒和NL63.3等季节性冠状病毒方面表现有前途.
结论:
- 持续的病毒进化需要适应性治疗策略,超越目前的单克隆抗体和疫苗.
- 基于ACE2的疗法代表了对正在演变的SARS-CoV-2 Omicron变种和潜在的其他SARS冠状病毒的有希望的,持久的解决方案.
- 对基于ACE2的病毒捕获分子的进一步研究可能会导致针对当前和未来的冠状病毒威胁的广泛抗病毒治疗.
相关概念视频
00:36Viral Mutations
32.3K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.3K
01:05Single Nucleotide Polymorphisms-SNPs
15.0K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.0K
02:28Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K